Business Wire

LINTEC Announces Four New Adhesive Materials for Labels

Del

LINTEC Corporation (TOKYO: 7966) announced on September 20 that it will launch four newly developed label adhesive materials sequentially from October 2017. The new products will be on display prior to launch at Labelexpo Europe 2017, the world’s largest trade show in the label field.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170920005611/en/

LINTEC's super-strength adhesive labelstocks (Photo: Business Wire)

LINTEC's super-strength adhesive labelstocks (Photo: Business Wire)

Overview of Labelexpo Europe 2017
Date: September 25 (Mon.) to 28 (Thurs.)
Venue: Brussels Expo, Belgium
LINTEC Booth: Hall 3 3C 15
LINTEC Press Conference: 11:00 a.m. to 11:30 a.m., September 25, held in the Brussels Expo Press Office Theater

Super-strength adhesive labelstocks: Extreme adhesion for rough surfaces

Characterized by very strong adhesiveness that enables not only firm affixing to surfaces to which labels are difficult to affix such as rough surfaces, polypropylene, and polycarbonates, making it suitable for uses such as warning labels for electrical devices and security labels. In addition, strong adhesion between two adhesive surfaces makes this labelstock suitable for baggage tags.

Ultra low-migration labelstocks: Safe for display labels on plastic containers

With an extremely low content of low molecular weight components that can permeate low-barrier plastics and result in contamination of contained liquids, this adhesive is ideal for use with medical and pharmaceutical products. Demand for low-migration labelstocks is expected to increase as medical and pharmaceutical industries increasingly use light and durable plastic containers instead of high-barrier glass containers that break more easily.

Note: Tatsuya Tsukida, LINTEC's Executive Officer, General Manager, Research & Development Division and Research Center is scheduled to give a presentation about these labelstocks at the Labelexpo Press Office from 11:00 to 11:30 am on 25 September (Mon.).

3D comfortable labelstocks: Suitable for three-dimensionally curved and irregular surfaces

These labelstocks are extremely thin, with a total thickness of 45 μm for the facestock and adhesive, and adhere firmly to surfaces with complex curves or other irregular features. The facestock is a specialized, non-PVC film, while the label is transparent and weather-resistant, suitable even for outdoor use. The labelstocks are ideal for decorations on racing cars and motorcycles as well as labels on scale models, soft packages and more.

Laser-markable labelstocks: Resistant to chemicals and abrasion

These labelstocks consist of a transparent film facestock and a white adhesive that goes black when irradiated with an yttrium-aluminum-garnet laser. As a result, lettering can be produced with laser irradiation on the undersurface of the label. The lettering surface, a part of the adhesive rather than the facestock, is not exposed, which makes it highly resistant to chemicals and abrasion and prevents tampering. This makes the labelstocks ideal for name plates, warning labels, in-process control labels, vehicle identification number (VIN) labels and more.

LINTEC’s Labelexpo Europe 2017
http://www.lintec-global.com/labelexpo/

Leading up to Labelexpo Europe 2017, LINTEC has created a special website that will be updated with information about products to be exhibited, follow-up information after the expo, and messages from the Director of the Business Division for members of the media and visitors to the site.

All photograph data used in this press release can be downloaded from
http://www.lintec-global.com/1702.zip

Contact information

Inquiries about this press release
Dentsu Public Relations for LINTEC Corporation
Tim Yoshida
lintec@group.dentsu-pr.co.jp

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Kite Announces Data From ZUMA-3 Study of KTE-C19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia12.12.2017 00:30Pressemelding

Kite, a Gilead Company (Nasdaq: GILD), announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen receptor T (CAR T) cell therapy, which is investigational for the treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL). With a minimum of eight weeks of follow-up, 71 percent of ALL patients (n=17/24) who received a single infusion of KTE-C19 achieved complete tumor remission (complete remission (CR) or CR with incomplete hematological recovery). The ZUMA-3 study results were presented in an oral session at the Annual Meeting of the American Society of Hematology (ASH) in Atlanta. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005311/en/ ALL is an aggressive type of blood cancer which can also involve the lymph nodes, spleen, liver, central

NTT Communications Strengthens its DDoS Protection Services with New Detection Solution11.12.2017 23:00Pressemelding

NTT Communications Corporation (NTT Com), the global data and IP services arm of Fortune Global 500 telecom leader NTT (TYO: 9432), announced that it is expanding its Distributed Denial of Service Protection Services (DPS) with the addition of DPS Detect. This new solution can help customers detect potential attacks directed to their networks and initiate mitigations faster. DDoS attacks can strike at any time, potentially crippling network infrastructure and severely degrading the performance and reachability of a website or other IP-accessible assets. The expanded DPS suite of services will enable Global IP Network customers around the world to easily customize the level of service and assistance that best fits their needs. “Network security is one of the top priorities for our company,” said Michael Wheeler, executive vice president of the NTT Communications

Interactive Brokers Launches Bitcoin Futures Trading at the Start of Trading December 10th, 201711.12.2017 16:28Pressemelding

Interactive Brokers Group, Inc. (NASDAQ GS:IBKR), a global electronic brokerage firm, began offering clients the ability to trade bitcoin futures at the start of trading on the Cboe Futures Exchange (CFE) on Sunday night, December 10th, 2017. In addition to offering bitcoin futures from the CFE, under the ticker symbol GXBT, the company plans to offer bitcoin futures from the Chicago Mercantile Exchange (CME) at the scheduled start of trading December 18th using the symbol BRR. IBKR was there at the start of trading and its systems operated normally. “Interactive Brokers was on the buy side of the low print of 14,710,” said Thomas Peterffy, founder, Chairman and CEO of Interactive Brokers. “A Registered Investment Advisor on the Interactive Brokers platform purchased two March contracts in the first minute of trading.” As of 9:15am ET on Monday, the company said that

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 201711.12.2017 13:00Pressemelding

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research strategy – investigating both cancer cell-directed therapies and immune cell-directed therapies. This multi-faceted approach offers the potential to bring innovative opportunities to the Boehringer Ingelheim oncology portfolio and novel therapies to patients. “Immuno-oncology is radically shifting the research and treatment landscape in oncology. We believe that the greatest success in difficult-to-treat cancers will be achieved with immuno-oncology and its combination with cancer cell directed therapy, which is why we are committing significant resources in both areas,” said Jonathon Sedgwick, Ph.D., Vice

Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses11.12.2017 12:47Pressemelding

The Valence Group acted as lead financial advisor to SK Capital Partners on its announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd. (“ICL”) for approximately $1 billion. The transaction is expected to close during the first half of 2018. The Businesses, headquartered in St. Louis, Missouri, have global operations and are market leaders in each of their segments. The ICL Fire Safety business is a formulator and manufacturer of fire management chemicals. Its Phos-Chek fire retardants, Class A and B foams, and water enhancing gels are the world’s leading chemical solutions for managing wildland, military, industrial and municipal fires, and are used in partnership with fire management agencies across the globe. The ICL Oil Additives business provides high quality phosphorus pentasulfide used in the preparation of ZDDP-based lubricant additives, i

Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care11.12.2017 10:18Pressemelding

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:X TM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005434/en/ Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom